COVID-19 Business Intelligence and Analysis for Clinical Laboratories, Pathology Groups and Hospital Administration

COVID-19 Briefings

Reliable COVID-19 Business Intelligence and analysis for clinical laboratories, pathology groups and Laboratory Diagnostics.

CDC Considering Requiring COVID-19 Testing for All Domestic Travel

CDC orders airlines to verify and confirm documentation for SARS-CoV-2 COVID-19 negative test
Share on facebook
Share on twitter
Share on linkedin
Share on pinterest
Share on whatsapp
Share on email
Share on facebook
Share on twitter
Share on linkedin
Share on google
Share on whatsapp
Share on email

Travel within the United States may require negative COVID-19 result if CDC implements contemplated changes 

The US Centers for Disease Control and Prevention (CDC) recently instituted new requirements for international travel (See New COVID-19 Travel Testing Order Set to Go into Effect Jan. 26). These new guidelines require that all passengers traveling into the United States have a recent, valid COVID-19 test showing that they are negative for the infection.

During a call with reporters Jan. 26, 2021, Marty Cetron, MD, CDC Director for Global Migration and Quarantine, indicated that the CDC is requiring even more stringent testing requirements for travelers. “In the President’s executive order we also have to look at the possible planning in domestic travel,” Cetron said. “These are conversations that are ongoing and looking at what the types and locations of testing might be. So this is another one of those ‘follow that space.’ We’re actively looking at it.”

The indication that testing could be considered for all domestic flights in addition to existing international requirements will be very impactful for clinical laboratories if instituted. The CDC has not yet officially released any new requirements, but many expect these requirements may be instituted soon.

Related Resources:


Helping Your Lab Stay Afloat During Challenging Times

Dear Colleague,

Robert L. MichelIn these challenging times for our colleagues in clinical laboratories, pathology practices and hospital administration, The Dark Intelligence Group (TDIG) — through generous grants from our partners — is bringing you the COVID-19 STAT Intelligence Briefings.

We’ve added analysts, writers and skilled editors to the COVID-19 STAT team to uncover, analyze, and immediately report to you what’s happening with the SARS-CoV-2 pandemic, packaged with the insights you need to deliver quality testing for patient care and keep your lab’s financial ship afloat. As part of our mission, we are also bringing you real-time data from our partners around testing that you will not find anywhere else.

Please let me know how we can better improve this service to fit your needs. If you would like to offer a grant to keep our mission going with this site, please contact me at


Robert L. Michel
President, Founder
The Dark Intelligence Group